Cargando…
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target
The benefits of novel oral anticoagulants are hampered by bleeding. Since coagulation factor IX (fIX) lies upstream of fX in the coagulation cascade, and intermediate levels have been associated with reduced incidence of thrombotic events, we evaluated the viability of fIXa as an antithrombotic targ...
Autores principales: | Ankrom, Wendy, Wood, Harold B., Xu, Jiayi, Geissler, Wayne, Bateman, Tom, Chatterjee, Manash S., Feng, Kung‐I, Metzger, Joseph M., Strapps, Walter R., Tadin‐Strapps, Marija, Seiffert, Dietmar, Andre, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777260/ https://www.ncbi.nlm.nih.gov/pubmed/26977298 http://dx.doi.org/10.1002/prp2.207 |
Ejemplares similares
-
Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit
por: Chen, Zhu, et al.
Publicado: (2015) -
Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth
por: Khan, Tayeba, et al.
Publicado: (2016) -
Molecular Dynamics Simulation Study of the Selective Inhibition of Coagulation Factor IXa over Factor Xa
por: Yoon, Hyun Jung, et al.
Publicado: (2023) -
Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential
por: Nakajima, Yuto, et al.
Publicado: (2022) -
ApoB siRNA-induced Liver Steatosis is Resistant to Clearance by the Loss of Fatty Acid Transport Protein 5 (Fatp5)
por: Ason, Brandon, et al.
Publicado: (2011)